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Abstract 
 
Ras homologue enriched in striatum (Rhes) is a small monomeric G protein which functions 
in a variety of cellular processes, including attenuation of G protein-coupled receptor (GPCR) 
signalling. There have been many studies into the effects of Rhes, but there is no molecular 
information about how Rhes might bring about these effects. Rhes shares striking sequence 
homology to AGS1 (activator of G protein signalling 1) and we considered whether the two 
proteins function in similar ways. AGS1 binds to the Gβ1 subunit of heterotrimeric G proteins 
and we have used yeast two-hybrid studies to show that Rhes binds selectively to Gβ1, Gβ2 
and Gβ3 subunits. Binding to the Gβ subunits involves the cationic regions of AGS1 and 
Rhes, and we used Rhes-AGS1 chimeras to show that their different cationic regions 
determine the Gβ-specificity of the interactions. Possible implications of this interaction for 
the activity of Rhes are discussed. 
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Introduction 
 
The Ras superfamily of small GTPases comprises several protein subfamilies (Figure 1A, 
[1]). Sequence analysis identifies two family members, Rhes and AGS1, as a distinct subclass 
with an additional domain in the carboxyl terminal region of the protein. This domain has 
been termed the “cationic region” as it is enriched in positively charged residues (Figure 1B). 
As well as their sequence similarity, both proteins are expressed in response to hormones; 
Rhes expression is regulated by thyroid hormone during the postnatal period [2], whereas 
AGS1 is induced by dexamethasone (as indicated by its original name Dexras1) [3]. Both 
proteins have also been implicated in signalling pathways downstream of G protein-coupled 
receptors (GPCRs). 
 
GPCRs represent the largest family of cell surface receptors and are characterised by seven 
transmembrane helices. In the unstimulated state, the receptor is associated with a 
heterotrimeric complex of Gα, Gβ and Gγ subunits in which the Gα subunit is bound to GDP. 
Activation of the receptor stimulates the exchange of GDP for GTP, releasing the Gα-GTP 
and Gβγ subunits to activate a variety of downstream effectors that are responsible for 
bringing about the changes in cell behaviour. Gα proteins possess an intrinsic GTPase activity 
and GTP hydrolysis returns the heterotrimer to its inactive state. The specificity, magnitude 
and duration of GPCR signalling is further regulated by accessory proteins that interact with 
the receptors, the G proteins or the effectors. These include receptor kinases (reviewed by 
[4]), regulator of G protein signalling (RGS) proteins (reviewed by [5,6]), and activator of G 
protein signalling (AGS) proteins (reviewed by [7,8]). The realisation that heterotrimeric G 
proteins can function in cellular processes independently of the receptors [9] illustrates how 
significant the regulation by these accessory proteins can be in some circumstances. 
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AGS1/DexRas1 was first identified in mice [3] and its human homologue was isolated in a 
yeast screen for receptor-independent activators of heterotrimeric G proteins [10,11]. In vitro 
analyses suggested that AGS1 mimics activated receptors by binding to Gα subunits and 
promoting nucleotide exchange [10,11], and is consistent with in vivo evidence that AGS1 
activates both Gα- [12,13] and Gβγ-mediated signalling pathways [11,14] in the absence of 
ligand. However, the ability of AGS1 to inhibit receptor-activated Gβγ-mediated signalling 
[11,14,15,16] suggested additional activities and we previously used yeast two-hybrid 
analysis to reveal a novel interaction between AGS1 and Gβ1 [17]. The interaction between 
the C-terminal cationic region of AGS1 and blades 3-to-7 of the Gβ1 propeller structure 
might explain how AGS1 promotes Gαβγ dissociation in the absence of receptor stimulation 
but selectively inhibits Gβγ-mediated signalling in receptor-stimulated pathways [8]. 
 
There is increasing evidence that Rhes regulates signalling pathways involving GPCRs and 
heterotrimeric G proteins; it attenuates signalling via the cAMP/PKA pathway mediated by 
both wild-type thyroid stimulating hormone (TSH) receptors and constitutively active β2-
adrenergic receptors [18], inhibits signalling from a variety of other receptors [19], and 
modulates dopamine signalling [20]. How Rhes achieves this is unclear, although its lack of 
effect on either a constitutively active Gα subunit or a directly activated effector protein 
(protein kinase A activated by forskolin) [18] suggests that Rhes might be acting on the 
heterotrimeric Gαβγ complex. Given the functional similarity between Rhes and AGS1, and 
the striking sequence homology between the two proteins (particularly with regards to their 
novel cationic regions), we investigated whether Rhes, like AGS1, interacts with Gβ subunits. 
Using the yeast two-hybrid system, we demonstrate that Rhes interacts selectively with Gβ1, 
Gβ2 and Gβ3 and that the interaction, like that between AGS1 and Gβ1 [17], involves the 
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cationic region of Rhes and blades 3-to-7 of the Gβ propellers. Analysis of AGS1-Rhes 
chimeras suggests that the different cationic regions specify their interactions with the Gβ 
subunits. The interaction between Rhes and Gβ subunits revealed in this study could explain 
how Rhes can influence signalling through heterotrimeric G proteins. 
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Materials and methods 
 
Yeast two-hybrid assays 
The AH109 Saccharomyces cerevisiae strain, pGADT7-SV40, pGBKT7-p53, and pGBKT7-
lamin-C constructs used in this study were supplied with the Matchmaker yeast two-hybrid kit 
and all yeast-based methods were carried out as detailed by the manufacturer (BD Biosciences 
Clontech, Oxford, UK; kit version PT13529-1). Two-hybrid assays were carried out following 
sequential transformations of AH109 with pGBKT7-based plasmids and then pGADT7-based 
plasmids. Co-transformants were maintained on MM (a defined minimal medium lacking 
leucine and tryptophan) prior to screening for interactions. Cell concentrations were 
determined using a Coulter Channelyser (Beckman-Coulter, Luton, UK). All experiments to 




DNA manipulations were performed by standard methods. Amplification by the polymerase 
chain reaction (PCR) was performed in 70 µl reactions using Pwo DNA polymerase from 
Pyrococcus woesei according to the supplier’s instructions (Roche Molecular Biochemicals, 
Lewes, UK). Oligonucleotides were synthesised by TAGN Newcastle (Gateshead, 
Northumbria, UK). All DNA constructs were sequenced to confirm that no errors had been 
introduced during amplification. 
The full-length Gβ subunits (Gβ1, Gβ2, Gβ3, Gβ4 and Gβ5) and the deleted Gβ1 constructs 
(Gβ1WD1-7, Gβ1WD3-7, Gβ1WD5-7) were expressed as fusions with the GAL4 Activation Domain 
from the pGADT7 vector as described previously [17]. 
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The Rhes open reading frame (ORF) was amplified by PCR from placental cDNA using 
JO1939 (5’ gggcatATGATGAAGACTTTGTCCAGC, sense primer containing an NdeI site 
and initiator codon in bold, lowercase letters indicate sequence not found within the gene 
being amplified) and JO1940 (5’ ggggatccTCACTGGATGGTGCACTTGTCCCTCT; 
antisense primer containing a BamHI site and TCA stop anticodon) and cloned into the NdeI-
BamHI sites of the yeast two-hybrid bait vector pGBKT7 to generate pGBKT7-Rhes. 
RhesΔCR (Rhes construct lacking the region Met189-Ala235) was generated by inverse PCR on 
pGBKT7-Rhes using JO2179 (5’ CGCCGCCCCAGCGTCAACAGTGACCTCAAG; sense 
primer containing the CGC codon corresponding to Arg236 of Rhes) and JO2178 (5’ 
GCTGAAGAGCACGTAGAACATCTCG; antisense primer containing the GCT anticodon 
corresponding to Ser188 of Rhes) and ligating the product to itself. 
Rhes189-235 (construct corresponding to the region Met189-Ala235 of Rhes) was amplified using 
JO2184 (5’ gggcatATGGCCAAGCTGCCCCACGAGAT; sense primer containing an NdeI 
site and the ATG codon corresponding to Met189 of Rhes) and JO2185 (5’ 
ggggatcctcaGGCGAAGGGCGAGACCATGCCAT; antisense primer containing a BamHI 
site and a stop anticodon immediately downstream of the GGC anticodon corresponding to 
Ala235 of Rhes) with pGBKT7-Rhes as template.) and cloned into the NdeI-BamHI sites of the 
yeast two-hybrid bait vector pGBKT7 to generate pGBKT7-Rhes189-235. 
RhesCR-AGS1 (construct in which the cationic region of Rhes [Met189-Ala235] was replaced by 
the equivalent region of AGS1 [Met194-Ala250]) was created by ligating the inverse PCR 
product generated for the construction of RhesΔCR (see above) to the PCR product obtained on 
pGBKT7-AGS1 [17] using JO2175 (5’ ATGGCCAAGCTGCCCAGCGAG; sense primer 
containing the ATG codon corresponding to Met194 of AGS1) and JO2174 (5’ 
CGCGAAGGGTGCCACGATGCCAAAGGC; antisense primer containing the CGC 
anticodon corresponding to Ala250 of AGS1). 
Hill et al. Page 9 
AGS1CR-Rhes (construct in which the cationic region of AGS1 [Met194-Ala250] was replaced by 
the equivalent region of Rhes [Met189-Ala235]) was created by ligating the product generated 
by PCR on pGBKT7-Rhes with JO2181 (5’ ATGGCCAAGCTGCCACACGAG; sense 
primer containing the ATG codon corresponding to Met189 in Rhes) and JO2180 (5’ 
GGCGAAGGGCGAGACCATGCC; antisense primer containing the GGC anticodon 
corresponding to Ala235 of Rhes) to the product obtained by inverse PCR on pGBKT7-AGS1 
using JO2173 (5’ CGCCGGCCCAGCGTACACAGC; sense primer containing the CGC 
codon corresponding to Arg251 in AGS1) and JO2172 (5’ 
GGCGAAGAGCGCGCGGAACATCTG; antisense primer containing the GGC anticodon 
corresponding to Ala193 of AGS1). 
 
Western blotting  
Western blotting was performed as described previously [17]. Mouse monoclonal anti-GAL4 
binding domain (BD) and mouse monoclonal anti-GAL4 activation domain (AD) were used 
according to manufacturers’ instructions (BD Biosciences, Oxford, UK). HRP-conjugated 
secondary antibodies were from either Amersham plc (Little Chalfont, UK) or Roche 
Diagnostics (Lewes, UK) and used according to the manufacturer’s instructions. 
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Results 
 
Rhes binds selectively to human Gβ subunits 
Yeast two-hybrid analysis was used to investigate interactions between Rhes and each of the 
five human Gβ subunits (Figure 2). The yeast screening strain AH109 was transformed first 
with pGBKT7-Rhes and then with the various pGADT7-Gβ constructs and co-transformants 
isolated on selective medium. Growth on MM (a defined minimal medium lacking leucine 
and tryptophan) confirmed the presence of the complementing plasmids in each isolate. The 
formation of blue colonies on MM-His-Ade+Xαgal (MM lacking histidine and adenine but 
incorporating 5-bromo-4-chloro-3-indolyl-α-D-galactoside [Xαgal]) indicated that interaction 
between Rhes and the Gβ1, Gβ2 and Gβ3 subunits (but not Gβ4 nor Gβ5) had resulted in 
expression of the HIS3, ADE2 and MEL1 reporter genes. A positive control for interacting 
proteins was provided by transformants expressing SV40-T antigen and p53, proteins that 
interact strongly [21]. In contrast, SV40-T antigen does not interact with lamin-C and co-
transformants were unable to grow on plates lacking histidine and adenine. Immunoblotting 
confirmed expression of Rhes and each of the Gβ subunits in the various transformants; 
fusion of Rhes to the GAL4 DNA binding domain (BD) in pGBKT7 increases its MW from 
~30 kDa to ~53 kDa (note that the antibody to GAL4-BD detects a faint product at ~35 kDa 
in all samples, including those not expressing the fusion protein), fusion of the Gβ subunits to 
the GAL4 activation domain (AD) in pGADT7 increases their MWs from ~37 kDa to ~55 
kDa. The interactions were quantitated using a liquid-based β-galactosidase assay for 
expression of the LacZ reporter gene. Under the conditions used, strongly interacting proteins 
(such as SV40-T antigen and p53) generate ~4.5 Units of β-galactosidase activity, while non-
interacting proteins (such as SV40-T antigen and lamin-C) generate less than 0.5 Units. Co-
transformants expressing Rhes and Gβ1, Gβ2 or Gβ3 produced ~3 Units of activity, 
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suggesting a reasonably strong interaction. In contrast, strains expressing Rhes and either Gβ4 
or Gβ5 produced less than 0.5 Units, indicating these proteins do not interact. 
 
Neither Rhes nor any of the Gβ subunits supported growth on the MM-His-Ade+Xαgal plates 
when expressed on their own (not shown), demonstrating they have no inherent ability to 
activate transcription of the reporter constructs. Furthermore, transferring Rhes and the Gβ 
subunits from their original two-hybrid plasmids to the complementing plasmids to provide 
the reciprocal pairing for analysis generated interactions that were indistinguishable from 
those in Figure 2, confirming that induction of reporter activity was due to an interaction 
between Rhes and Gβ1, Gβ2 and Gβ3 and not to non-specific effects arising from expression 
of these proteins as fusions with either the GAL4 binding domain or GAL4 activation 
domains. We have shown previously that each Gβ subunit was able to interact in the two-
hybrid system with Gγ4 [22], a human Gγ subunit that binds to Gβ subunits in vivo [23]. 
 
 
Mapping the Rhes interaction site on Gβ1 
Gβ subunits contain two structurally distinct domains, an N-terminal α-helix of ~20 amino 
acids which forms a coiled-coil interaction with Gγ subunits, and a seven-bladed propeller 
structure formed from the repeating WD repeat motifs that is believed to interact with binding 
partners [17,24,25,26]. Each propeller blade consists of a single WD repeat organised into 
four twisted β-strands, and variable regions between each repeat make it straightforward to 
generate constructs containing different numbers of blades. As constructs require an odd 
number of blades to be stable, and blade 7 provides a ‘velcro snap’ to close the propeller, only 
a limited series of Gβ1 constructs were tested for their ability to interact with Rhes (Figure 
2B). Immunoblotting demonstrated expression of Rhes and each of the Gβ1 constructs (Gβ1 
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constructs are expressed as fusions to the activation domain from pGADT7 and were detected 
using an antibody to the activation domain, and the activation domain adds ~18 kDa to the 
MW of the Gβ1 constructs), while control experiments confirmed that neither Rhes nor the 
Gβ1 constructs were able to induce reporter genes when expressed on their own (not shown). 
Removal of either the N-terminal α-helix or the first two propeller blades of Gβ1 did not 
affect its interaction with Rhes. However, Gβ1WD5-7 (lacks blades 1-to-4) failed to interact 
with Rhes, suggesting that this region is required for the interaction. The same region of Gβ1 
was previously identified as being required for its interaction with AGS1 [17]. 
 
 
Mapping the Gβ interaction site on Rhes 
Rhes is similar to Ras and other small monomeric G proteins except for a C-terminal cationic 
region (residues Met189-Ala235; Figure 1B). A similar cationic region in the highly 
homologous AGS1 mediates its interaction with both the neuronal nitric oxide adaptor protein 
CAPON [27] and Gβ1 [17], and we used two-hybrid analysis to investigate the role of this 
region in the interaction of Rhes with the Gβ subunits (Figure 3). Immunoblotting confirmed 
that all of the constructs were expressed, and none of the constructs induced expression of the 
reporter genes when present on their own (not shown). A Rhes construct lacking the cationic 
region (RhesΔCR, lacks residues Met189-Ala235) failed to interact with any of the Gβ subunits 
(Figure 3A), whereas a construct containing just this region of Rhes (fused to the GAL4 
binding domain) interacted with Gβ1, Gβ2 and Gβ3 (Figure 3B). Thus, the cationic region of 
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The cationic region determines the specificity of the Gβ interactions 
The cationic regions of both AGS1 [17] and Rhes (Figure 3) are required for their interactions 
with Gβ subunits. However, the two regions are very different in the two proteins (Figure 1B) 
and we wondered whether these differences were responsible for their different Gβ 
specificities; both AGS1 and Rhes bind to Gβ1, but only Rhes also binds to Gβ2 and Gβ3. 
We therefore generated constructs that exchanged the cationic regions between the two 
proteins, and used two-hybrid analysis to examine their ability to interact with the various Gβ 
subunits (Figure 4). Immunoblotting confirmed that all of the constructs were expressed, and 
none of the constructs induced expression of the reporter genes when present on their own 
(not shown). RhesCR-AGS1, which has residues Met189-Ala235 of Rhes replaced by residues 
Met194-Ala250 of AGS1, interacted with only Gβ1 and, unlike wild type Rhes, was unable to 
interact with either Gβ2 or Gβ3 (Figure 4A). In contrast, AGS1CR-Rhes, (Met194-Ala250 of 
AGS1 replaced by residues Met189-Ala235 of Rhes) interacted with Gβ1, Gβ2 and Gβ3 (Figure 
4B). These results suggest that the different cationic regions of Rhes and AGS1 interact with 
different Gβ subunits. 
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Discussion 
 
Our data suggest that Rhes interacts specifically with the Gβ1, Gβ2 and Gβ3 subunits of 
heterotrimeric G proteins, but not Gβ4 or Gβ5. The interaction involves the C-terminal 
cationic region of Rhes and blades 3-to-7 of the Gβ subunits, and appears similar to the 
interaction between the cationic region of AGS1 and blades 3-to-7 of Gβ1 [17]. Indeed, 
exchanging the cationic regions between Rhes and AGS1 alters the Gb-binding specificities 
of the chimeras. 
 
The interaction of Rhes with the Gβ subunits requires its C-terminal cationic region. This 
region identifies Rhes and AGS1 within the Ras-like family of small G proteins and was 
previously shown to mediate the interaction of AGS1 with Gβ1 [17]. Despite both binding to 
Gβ1, there is no obvious sequence homology between the cationic regions of Rhes and AGS1, 
and any shared activities are presumably not dependent upon precise residues. But there is a 
level of specificity in the interaction in that the cationic region of AGS1 interacts with Gβ1 
while the cationic region of Rhes also interacts with Gβ2 and Gβ3. The cationic region of 
AGS1 also interacts with the neuronal nitric oxide adaptor protein CAPON [27]. It is 
therefore possible that this domain allows both AGS1 and Rhes to interact with a wide variety 
of other molecules. These may be responsible for the effects of Rhes and AGS1 that do not 
appear to be mediated through G proteins. 
 
The Rhes-Gβ1 interaction requires blades 3-to-7 of the Gβ β-propeller. Given the 
conservation of sequence and structure between Gβ subunits, it seems likely that the same 
regions of Gβ2 and Gβ3 are involved in their interaction with Rhes. Our previous study 
identified the same region of Gβ1 to be involved in its interaction with AGS1 [17]. This 
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region of Gβ1 is not generally thought to be involved in interactions with its other binding 
partners. Gγ subunits, for example, form a coiled-coil interaction with the N-terminal α-helix 
of the Gβ subunit [28], while Gα subunits are believed to interact with blades 1-to-3 of the β-
propeller [28], and target effector proteins primarily contact the outer segments of blades 1 
and 2 [29,30]. However, overlapping binding sites and more complex interactions, especially 
between Gβ subunits and target effectors, might further complicate the interactions. We 
cannot, for example, rule out a requirement for blade 3 in binding Rhes, or AGS1, as well as 
its role in binding Gα subunits. It is also possible that binding of a protein to one part of the 
Gβ subunit could affect the binding of a second protein to a different part of the same Gβ 
molecule. 
 
Rhes has complex effects on GPCR signalling [18,19]. It attenuates signalling by GPCRs that 
function through Gαs but does not appear to affect signalling through Gαi subunits. The effect 
on Gαs signalling appears to be at the level of activation of the heterotrimer Gαβγ complex as 
constitutively active receptors are affected, but constitutively active Gαs subunits are not, and 
Rhes has no effect on direct activation of the cAMP/PKA pathway by forskolin. These results 
suggest that Rhes can affect the coupling of GPCRs to Gαs subunits. The interaction of Rhes 
with Gβ subunits revealed in our study could provide a mechanism for this inhibition, either 
by disrupting the formation of heterotrimeric G proteins or inhibiting the interaction of the 
heterotrimer with the receptor. Rhes appears perfectly located within the cell to have such 
affects. Like the G protein subunits, Rhes is not an integral membrane protein but associates 
with the plasma membrane through post-translational modifications. For Rhes, this is via 
prenylation of a conserved CAAX motif at its C-terminus [18]. Gγ subunits are also C-
terminally prenylated, Gαs subunits are N-terminally palmitoylated, and Gαi subunits are both 
palmitoylated and myristoylated at the N-terminus (reviewed by [31]). Gβ subunits associate 
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indirectly with membranes though interaction with the Gγ subunits, and this could be 
sensitive to inhibition by the membrane localised Rhes. 
 
Why Rhes affects only Gαs signalling, and not Gαi signalling, is an interesting challenge [18]. 
One possibility could relate to the Gβ-specificity of Rhes (Figure 2A) and it might be, for 
example, that Gαs subunits interact preferentially with Gβ1-3 (and thus be affected by Rhes) 
whereas Gαi subunits are more often complexed with Gβ4-5 (and not affected by Rhes). 
Alternatively, Gαi may be less susceptible than Gαs to disruption by Rhes because Gαi has a 
stronger interaction with the plasma membrane and may be better able to interact with Gβγ 
subunits and/or receptors. Gαi is both myristoylated and palmitoylated whereas Gαs is only 
palmitoylated and requires interaction with Gβγ subunits for full membrane association, the 
prenylated Gγ subunit providing a second membrane anchor [32] (reviewed by [33]). Indeed, 
Gαs associates poorly with membranes in the absence of Gβγ subunits, and requires this 
interaction for efficient palmitoylation [34]. The greater membrane association of Gαi may 
overcome the inhibitory effects of Rhes more readily than Gαs. 
 
As a final consideration, Rhes functions independently of G proteins, binding to effector 
proteins such as Raf and phosphoinositide 3-kinase  [18]. It will be interesting to determine if 
these more traditional targets for Ras-like proteins also interact with the cationic region of 
Rhes or whether they interact with other parts of the Rhes molecule. 
 




Rhes and AGS1 comprise a distinct sub-family of the Ras G protein family. A) Schematic 
phylogenetic tree of selected members of the Ras superfamily, scale bar represents 0.1 
nucleotide substitutions per base. The tree was constructed using ClustalX [35] and visualised 
using TreeView version 1.6.6. B) Sequence comparison of Rhes, AGS1 and mammalian H-
Ras. Sequences were aligned using MultAlin version 5.4.1. [36] using symbol comparison 
table blosum62, gap weight 12 and gap length weight 2. Gaps introduced to maximise the 
alignment are indicated by ’-‘. Residues shaded in black are conserved in all three proteins, 
those in grey are in two of the proteins. Boxed regions correspond to interactions for the 
phosphate moieties of GTP/GDP (G1, G3), the GAP effector (G2), and the guanine nucleotide 
moiety (G4, G5). The cationic region (residues Met189-Ala235 of Rhes) is indicated by *. 
 
Figure 2 
Rhes interacts specifically with Gβ1, Gβ2 and Gβ3. A) Rhes (expressed from pGBKT7-Rhes) 
was co-expressed with each of the human Gβ subunits (expressed from pGADT7). All 
transformants grew on MM but only those containing Gβ1, Gβ2 or Gβ3 grew on MM-His-
Ade+XαGal, suggesting that only these Gβ subunits interact with Rhes to induce expression 
of the reporter genes. Control strains expressing the strongly interacting SV40-T antigen and 
p53 or the non-interacting SV40-T and lamin-C are included for comparison. A liquid-based 
β-galactosidase assay confirms that co-expression of Rhes and Gβ1, Gβ2 or Gβ3 induces 
expression of the LacZ reporter. B) Rhes was expressed separately with various Gβ1 
constructs lacking different parts of the protein. All transformants grew on MM but those 
containing Gβ1WD5–7 were unable grow on MM-His-Ade+XαGal, suggesting that this 
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construct was unable to interact with Rhes. Expression of Rhes in each strain was confirmed 
by immunoblotting with an antibody to the GAL4-BD (Rhes was fused to the GAL4 binding 
domain; note that the antibody to GAL4-BD detects a faint product at ~35 kDa in all samples, 
including those not expressing the Rhes fusion protein), and expression of the various Gβ 
constructs were confirmed by immunoblotting with an antibody to the GAL4-AD (the Gβ 
constructs are fused to the GAL4 activation domain). At least three separate isolates of each 
strain were subjected to immunoblotting to confirm that the results shown are representative. 
The β-galactosidase results are presented as the mean ± SD of three different isolates of the 




Binding of Gβ subunits to the cationic region of Rhes. A) Rhes lacking the cationic region 
(expressed from pGBKT7-RhesΔCR, lacks residues Met189-to-Ala235) was co-expressed with 
each of the Gβ subunits (expressed from pGADT7). All transformants grew on MM but none 
grew on MM-His-Ade+XαGal, suggesting that the cationic region of Rhes is essential for 
interaction with the Gβ subunits. The liquid-based β-galactosidase assay confirms that none 
of the combinations induced expression of the LacZ reporter. B) The cationic region of Rhes 
(expressed from pGBKT7-Rhes189-235, contains only those residues from Met189-to-Ala235) 
was co-expressed with human Gβ subunits (expressed from pGADT7). All transformants 
grew on MM but only those containing Gβ1, Gβ2 or Gβ3 grew on MM-His-Ade+XαGal, 
suggesting that the cationic region of Rhes is sufficient for the interaction with these Gβ 
subunits. The liquid-based β-galactosidase assay confirms that co-expression of Rhes189-235 
and Gβ1, Gβ2 or Gβ3 induces expression of the LacZ reporter. Expression of the various 
Rhes constructs were confirmed by immunoblotting with an antibody to the GAL4-BD (the 
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Rhes constructs were fused to the GAL4 binding domain), and expression of the various Gβ 
constructs were confirmed by immunoblotting with an antibody to the GAL4-AD (the Gβ 
constructs were fused to the GAL4 activation domain). At least three separate isolates of each 
strain were subjected to immunoblotting to confirm that the results shown are representative. 
The β-galactosidase results are presented as the mean ± SD of three different isolates of the 




The cationic regions of Rhes and AGS1 determine the specificity of their binding to Gβ 
subunits. A) Rhes containing the cationic region from AGS1 (pGBKT7-RhesCR-AGS1, residues 
Met189-to-Ala235 of Rhes replaced by residues Met194-to-Ala250 of AGS1) was co-expressed 
with the human Gβ1, Gβ2 and Gβ3 subunits (expressed from pGADT7). All transformants 
grew on MM but only the transformant containing Gβ1 grew on MM-His-Ade+XαGal and 
induced expression of the LacZ reporter, suggesting that RhesCR-AGS1 interacts with only Gβ1. 
B) AGS1 containing the catioinic region of Rhes (pGBKT7-AGS1CR-Rhes, residues Met194-to-
Ala250 of AGS1 replaced by residues Met189-to-Ala235 of Rhes) was co-expressed with the 
human Gβ1, Gβ2 and Gβ3 subunits (expressed from pGADT7). All transformants grew on 
MM and MM-His-Ade+XαGal, and all induced expression of the LacZ reporter, suggesting 
that AGS1CR-Rhes interacts with all three Gβ subunits. Expression of RhesCR-AGS1 and AGS1CR-
Rhes were confirmed by immunoblotting with an antibody to the GAL4-BD (the constructs are 
fused to the GAL4 binding domain), and expression of the Gβ constructs were confirmed by 
immunoblotting with an antibody to the GAL4-AD (the constructs are fused to the GAL4 
activation domain). At least three separate isolates of each strain were subjected to 
immunoblotting to confirm that the results shown are representative. The β-galactosidase 
Hill et al. Page 20 
results are presented as the mean ± SD of three different isolates of the relevant strain, each 
with duplicate determinations. 
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Rhes   1      MMKTLSSGNCTLSVPAKNSYRMVVLGASRVGKSSIVSRFLNGRFE 
AGS1   1 MKLAAMIKKMCPSDSELSIPAKNCYRMVILGSSKVGKTAIVSRFLTGRFE 
H-Ras   1                      MTEYKLVVVGAGGVGKSALTIQLIQNHFV 
 
 
Rhes  46 DQYTPTIEDFHRKVYNIRGDMYQLDILDTSGNHPFPAMRRLSILTGDVFI 
AGS1  51 DAYTPTIEDFHRKFYSIRGEVYQLDILDTSGNHPFPAMRRLSILTGDVFI 
H-Ras  30 DEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFL 
 
 
Rhes  96 LVFSLDNRESFDEVKRLQKQILEVKSCLKNKTKEAAELPMVICGNKNDHG 
AGS1 101 LVFSLDNRDSFEEVQRLRQQILDTKSCLKNKTKENVDVPLVICGNKGDRD 
H-Ras  80 CVFAINNTKSFEDIHQYREQIKRVK--------DSDDVPMVLVGNKCDLA 
 
 
Rhes 146 ELCRQVPTTEAELLVSGDENCAYFEVSAKKNTNVDEMFYVLFSMAKLPHE 
AGS1 151 FYREVDQREIEQLVGDDPQRCAYFEISAKKNSSLDQMFRALFAMAKLPSE 
H-Ras 122 -ARTVESRQAQDLARSYG--IPYIETSAKTRQGVEDAFYTLVREIR---- 
                                             ******* 
 
Rhes 196 MSPALHRKISVQYGDAFHPRPFCMRRVKEM----------DAYGMVSPFA 
AGS1 201 MSPDLHRKVSVQYCDVLHKKALRNKKLLRAGSGGGGGDPGDAFGIVAPFA 
H-Ras --- -------------------------------------------------- 
  ************************************************** 
 
Rhes 236 RRPSVNSDLKYIKAKVLREGQARERDKCTIQ 
AGS1 251 RRPSVHSDLMYIREKASAGSQAKDKERCVIS 
H-Ras 165 ------QHKLRKLNPPDESGPGCMSCKCVLS 
 
G1
G3
G5
G4
G2



